Retina Gallery ~ Full Sized Retina Images

Les plus populaires - Rapid severe macular atrophy with ranibizumab therapy for myopic CNVM 64 year old female with vision loss and distortion in the right and better eye from CNVM. Vision on presentation was 20/32 right eye and 3/200 left eye. She was treated with monthly Lucentis and the vision in the right eye declined to 20/200 in one year. Treatment was stopped and the vision improved to 20/80
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 452 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 437 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 424 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 422 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 418 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 416 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 412 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 408 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 405 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 403 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 403 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 403 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 402 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 402 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 402 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 400 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 400 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 398 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 397 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 395 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 394 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 392 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 392 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 391 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 390 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 387 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 385 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 385 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 384 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 383 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 383 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 382 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 382 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 382 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 381 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 380 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 377 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 368 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 364 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvu 359 fois64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
40 photos sur 1 page(s)

64 year old female with vision loss and distortion in the right and better eye from CNVM. Vision on presentation was 20/32 right eye and 3/200 left eye. She was treated with monthly Lucentis and the vision in the right eye declined to 20/200 in one year. Treatment was stopped and the vision improved to 20/80